EUVIMEDEUVIMED entdecken
Crossref

Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting

Poongkodi Karunakaran iD, Rangarajan Rajamanickam iD, Rajeev Parameswaran iD

World Journal of Surgery · 13.11.2026

DOI: 10.1002/wjs.70683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 13.11.2026. Verfasst von Poongkodi Karunakaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Government Mohan Kumaramangalam Medical College, Salem, Tamil Nadu, India. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Permanent hypoparathyroidism remains a significant complication after total thyroidectomy (TT), particularly with rising thyroid cancer incidence and increasing surgical extent. Long‐term consequences include hypocalcaemic symptoms, renal impairment, cardiovascular morbidity, neurocognitive dysfunction, reduced quality of life, and increased healthcare utilization. Although intact parathyroid hormone (iPTH) is the standard biomarker for diagnosis and surveillance, its availability and affordability remain limited in many low‐resource settings. This prospective study evaluated the utility of serum phosphate as a surrogate marker for permanent hypoparathyroidism after TT.

Methods

This cohort study compared patients with and without permanent hypoparathyroidism, defined as iPTH < 10 pg/mL persisting beyond 6 months post‐TT. Demographic, clinico‐pathological, and biochemical variables, including serum calcium, phosphate, iPTH, and 25‐hydroxyvitamin D (25OHD), were analyzed at baseline, postoperative day 2 (POD2), and 6 months.

Results

Among 328 patients (mean age 38.7 years; 77.1% women), transient postoperative hypoparathyroidism occurred in 195 (59.5%) and permanent hypoparathyroidism in 18 (5.5%). Multivariable analysis identified POD2 iPTH (odds ratio 10.7, 95% confidence intervals 1.3–88.1); parathyroid autotransplantation (OR 8.4[1.6–43.5]); six‐month phosphate (OR 3.9[1.2–13.5]); six‐month 25OHD level (OR 3.2[1.03–10.1]) and POD2 calcium (OR 1.7[1.0–3.0]) as independent predictors, each p < 0.05. In receiver operating characteristic analysis, both POD2 iPTH < 6 pg/mL (AUC = 0.781) and 6‐month phosphate > 4.9 mg/dL (AUC = 0.743) demonstrated good discriminatory performance ( p < 0.001) and were comparable by DeLong's test ( p = 0.671).

Conclusion

Postoperative iPTH below 6 pg/mL is the principal marker for early risk stratification of permanent hypoparathyroidism following TT, whereas persistent hyperphosphataemia may serve as a surrogate biochemical marker during long‐term surveillance.

Schlagwörter

Stichwörter der Autor:innen

hyperphosphataemiahypocalcaemiahypoparathyroidismparathyroid hormonethyroid cancerthyroidectomy

Autor:innen und Institutionen

  • Government Mohan Kumaramangalam Medical College, Salem, Tamil Nadu, India.
  • University Online Journal, Recognised PhD Guide, The Tamilnadu Dr MGR Medical University, Chennai, India.
  • Endocrine Surgery, National University Hospital, Singapore.

ORCID-Profile: Poongkodi Karunakaran, Rangarajan Rajamanickam, Rajeev Parameswaran

Zitieren

APA

Karunakaran, P., Rajamanickam, R., & Parameswaran, R. (2026). Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting. World Journal of Surgery. https://doi.org/10.1002/wjs.70683

Vancouver

Karunakaran P, Rajamanickam R, Parameswaran R. Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting. World Journal of Surgery. 2026. doi:10.1002/wjs.70683

BibTeX
@article{Karunakaran2026,
  author = {Karunakaran, Poongkodi and Rajamanickam, Rangarajan and Parameswaran, Rajeev},
  title = {Persistent Hyperphosphataemia as a Surrogate Marker of Permanent Hypoparathyroidism After Total Thyroidectomy in a Resource‐Limited Setting},
  journal = {World Journal of Surgery},
  year = {2026},
  doi = {10.1002/wjs.70683}
}
Kostenlos starten →